Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron J Keizer

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Journal of the Pediatric Infectious Diseases Society|January 3, 2018
Individualized Empiric Vancomycin Dosing in Neonates Using a Model-Based ApproachAdam Frymoyer, Chris Stockmann, Adam L Hersh, et al.
Plos Computational Biology|August 19, 2020
Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosisJohn Fors, Natasha Strydom, William S Fox, et al.
Trends in Pharmacological Sciences|December 4, 2024
Model-informed precision dosing in inflammatory bowel diseasesArno R Bourgonje, Marla C Dubinsky, Ron J Keizer, et al.
Jac-Antimicrobial Resistance|February 19, 2026
Vancomycin target attainment improved following population pharmacokinetic model switch: a large-scale quasi-experimental study of precision dosingDominic M H Tong, Jordan T Brooks, Ron J Keizer, et al.
Clinical Pharmacokinetics|July 9, 2010
Clinical pharmacokinetics of therapeutic monoclonal antibodiesRon J Keizer, Alwin D R Huitema, Jan H M Schellens, et al.
Current Clinical Pharmacology|January 18, 2011
Pharmacodynamic biomarkers in model-based drug development in oncologyRon J Keizer, Jan H M Schellens, Jos H Beijnen, et al.
Clinical Pharmacokinetics|November 20, 2022
Evaluation of Neonatal and Paediatric Vancomycin Pharmacokinetic Models and the Impact of Maturation and Serum Creatinine Covariates in a Large Multicentre Data SetJasmine H Hughes, Dominic M H Tong, Jonathan D Faldasz, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2019
Bayesian clinical decision support-guided versus clinician-guided vancomycin dosing in attainment of targeted pharmacokinetic parameters in a paediatric populationDavid M Hughes, Srijib Goswami, Ron J Keizer, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 27, 2018
Model-Informed Precision Dosing at the Bedside: Scientific Challenges and OpportunitiesRon J Keizer, Rob Ter Heine, Adam Frymoyer, et al.
Clinical Pharmacology and Therapeutics|March 7, 2020
Get Real: Integration of Real-World Data to Improve Patient CareRon J Keizer, Erik Dvergsten, Andrej Kolacevski, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Journal of the Pediatric Infectious Diseases Society|January 3, 2018
Individualized Empiric Vancomycin Dosing in Neonates Using a Model-Based ApproachAdam Frymoyer, Chris Stockmann, Adam L Hersh, et al.
Plos Computational Biology|August 19, 2020
Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosisJohn Fors, Natasha Strydom, William S Fox, et al.
Trends in Pharmacological Sciences|December 4, 2024
Model-informed precision dosing in inflammatory bowel diseasesArno R Bourgonje, Marla C Dubinsky, Ron J Keizer, et al.
Jac-Antimicrobial Resistance|February 19, 2026
Vancomycin target attainment improved following population pharmacokinetic model switch: a large-scale quasi-experimental study of precision dosingDominic M H Tong, Jordan T Brooks, Ron J Keizer, et al.
Clinical Pharmacokinetics|July 9, 2010
Clinical pharmacokinetics of therapeutic monoclonal antibodiesRon J Keizer, Alwin D R Huitema, Jan H M Schellens, et al.
Current Clinical Pharmacology|January 18, 2011
Pharmacodynamic biomarkers in model-based drug development in oncologyRon J Keizer, Jan H M Schellens, Jos H Beijnen, et al.
Clinical Pharmacokinetics|November 20, 2022
Evaluation of Neonatal and Paediatric Vancomycin Pharmacokinetic Models and the Impact of Maturation and Serum Creatinine Covariates in a Large Multicentre Data SetJasmine H Hughes, Dominic M H Tong, Jonathan D Faldasz, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2019
Bayesian clinical decision support-guided versus clinician-guided vancomycin dosing in attainment of targeted pharmacokinetic parameters in a paediatric populationDavid M Hughes, Srijib Goswami, Ron J Keizer, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 27, 2018
Model-Informed Precision Dosing at the Bedside: Scientific Challenges and OpportunitiesRon J Keizer, Rob Ter Heine, Adam Frymoyer, et al.
Clinical Pharmacology and Therapeutics|March 7, 2020
Get Real: Integration of Real-World Data to Improve Patient CareRon J Keizer, Erik Dvergsten, Andrej Kolacevski, et al.
Pageof 6